June 05, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
‘Pay attention’: Model detects patients overlooked for worse pancreatic cancer prognosis
Patients with pancreatic cancer who have “ultra-low baseline values” of a biomarker used for prognosis have similar survival as those who have the highest levels and are considered to have the worst outcomes.A dual-threshold model found PFS and OS did not differ for patients who had cancer antigen 19-9 (CA19-9) levels less than 7 U/mL or greater than 200 U/mL.
1,002 words~5 min read
